2015, Packaging, Regulations and Treatment

Q&A: The IND Journey Phase I – Navigating Success

Advarra

JULY 19, 2022

Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. A: Yes, the EUA is just temporary. of this guidance.

Packaging

Packaging FDA Regulations Trials

Commercial interests contribute to drug use and addiction

National Institute on Drug Abuse: Nora's Blog

SEPTEMBER 25, 2024

Great progress has been made in reducing smoking in the United States, which has led to major improvements in health, but the rapidly growing vaping industry, if not properly regulated, could jeopardize this. Such research can help guide policies as well as inform the development of evidence-based prevention and treatment interventions.

Drugs

Drugs Production Marketing Science

Article Periodic Thank You EPA orders manufacturer to stop producing PFAS and manufacturer petitions court

Agency IQ

DECEMBER 15, 2023

PFAS are used to repel water, oil, stains, and increase durability, and are found in a wide array of consumer and industrial products including non-stick cookware, fabric treatments, food packaging, cleaners, textiles, leather, cosmetics, paper and paints, fire-fighting foams (AFFF), and wire insulation. for uses under TSCA.

Packaging

Packaging Regulations Government Production

AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn’s Disease

The Pharma Data

JUNE 18, 2021

In the ADVANCE study, risankizumab showed efficacy regardless of prior treatment status by subgroup analysis in patients with moderate to severe Crohn’s disease, and non-bio-IR patients had numerically higher rates of efficacy compared to bio-IR patients. The MOTIVATE trial evaluated only bio-IR patients. percent on placebo.

Disease

Disease Therapies Treatment Clinical Trials

Phase 3 Maintenance Results Show Patients with Crohn’s Disease Receiving Risankizumab (SKYRIZI®) Achieved Endoscopic Response and Clinical Remission at One Year

The Pharma Data

JUNE 18, 2021

In this study, patients who responded to 12 weeks of risankizumab intravenous (IV) induction treatment (in a prior study) were re-randomized to receive risankizumab 180 mg, risankizumab 360 mg or withdrawal from risankizumab treatment (risankizumab IV induction-only control group). NORTH CHICAGO, Ill. percent and 4.5 percent and 3.4

Disease

Disease Treatment Therapies Trials

Analysis Chemical Thank You The 174 regulations the EPA is currently working on

Agency IQ

DECEMBER 15, 2023

The 174 regulations the EPA is currently working on The Environmental Protection Agency has unveiled its Fall 2023 Unified Agenda, which provides a look into the agency’s regulatory agenda for the upcoming year. The expected release dates of the agendas rarely line up exactly with the actual dates when the agency releases the regulation.

Regulations

Regulations Compliance Production Government

Analysis Chemical Thank You What we expect the EPA to do in April 2024

Agency IQ

MARCH 29, 2024

What we expect the EPA to do in April 2024 The top line: In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. PFAS regulations for drinking water.

Regulations

Regulations Compliance Production Government

Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023

Agency IQ

DECEMBER 1, 2023

What We Expect the FDA to do in December 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA

FDA Science Regulations Production

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Agency IQ

OCTOBER 27, 2023

What We Expect the FDA to do in November 2023 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA

FDA Science Regulations Production

Analysis Chemical Thank You What we expect the EPA to do in December 2023

Agency IQ

DECEMBER 1, 2023

What we expect the EPA to do in December 2023 In this returning feature, AgencyIQ looks at public data to determine what the Environmental Protection Agency is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations

Regulations Production Compliance Science

Analysis Chemical Thank You Highlights of the EPA’s Unified Agenda for Spring 2023

Agency IQ

JUNE 16, 2023

Highlights of the EPA’s Unified Agenda for Spring 2023 The Office of Management and Budget has released the Unified Agenda for Spring 2023, which outlines the regulations that agencies expect to release in 2023 and 2024. This information would be used in considering the regulation of asbestos.

Regulations

Regulations Compliance Production Science

Analysis Life Sciences Thank You Workshop addresses oncology dose optimization across full span of development

Agency IQ

FEBRUARY 23, 2024

As the name implies, the MTD seeks to find the highest dose of a treatment that can both be tolerated and treat the cancer. Additionally, this approach is generally no longer applicable to new treatments that are more targeted in their effects, such as immunotherapies and targeted small molecule therapies.

Science

Science FDA Trials Clinical Pharmacology

Unblock My Hormones And Start Burning Fat TODAY With HB5

The Pharma Data

MAY 13, 2021

Then these hormones can’t regulate your metabolism like they should…. In a 2015 study published in the Journal of Traditional and Complementary Medicine…. Along with the amount of estrogen-regulating DIM that he added as well. So go ahead and choose your discounted package of HB5 right now…. So what’s the fix here?

Production

Production Packaging Doctors Research

Analysis Chemical Thank You What we expect the EPA to do in February

Agency IQ

FEBRUARY 2, 2024

What we expect the EPA to do in February In this returning feature, AgencyIQ looks at public data to determine what the Environmental Protection Agency is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. The Agency expects to issue a final rule later in 2023.

Regulations

Regulations Compliance Engineering Government

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

Agency IQ

JULY 28, 2023

October 1, 2023 [link] Regulations Expected to be Published in Q3These are taken from the most recent version of the White House’s Unified Agenda. Specifically, this ANPRM seeks comments, research, information, data, and responses from certain categories of stakeholders that can inform the Agency’s modernization of FDA’s recall regulation.

FDA

FDA Science Biosimilars Regulations

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

JULY 31, 2023

135 (Winter 2015) (citation and quotation marks omitted). 2015), held that digital files for 3D printing were not material things as required to invoke the Tariff Act of 1930. 2003), an Internal Revenue Service regulation, excluded liability for “product” refund, repair or replacement. 2015) (collecting cases).

Production

Production International Trials Government

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

DECEMBER 29, 2023

Indeed, even the weird alternatives the plaintiff advocated, such as “point of sale” signs and DTC advertising (assuming these were Prop 65 remedies at all), were still FDA-regulated labeling. Alcozar didn’t buy it, since the particular regulations did not even apply to the clinics and health care providers that plaintiffs were targeting.

Testimonials

Testimonials FDA Drugs Vaccine

Pretty Potent Mix In A Prescription Painkiller Preemption Decision

Drug & Device Law

MAY 4, 2023

2015), finally gave appellate recognition to the preemption of design defect claims for FDA-approved branded prescription drugs. 25, 2023), is one we have been talking about for a long time. As detailed here , the decision in Yates v. Ortho-McNeil-Janssen Pharms., 3d 281 (6th Cir. Warner-Lambert & Co. , 3d 85, 98 (2d Cir.

FDA Approval

FDA Approval FDA Regulations Production

Drug Discovery Digest

Q&A: The IND Journey Phase I – Navigating Success

Commercial interests contribute to drug use and addiction

Trending Sources

Article Periodic Thank You EPA orders manufacturer to stop producing PFAS and manufacturer petitions court

AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab (SKYRIZI®) Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn’s Disease

Phase 3 Maintenance Results Show Patients with Crohn’s Disease Receiving Risankizumab (SKYRIZI®) Achieved Endoscopic Response and Clinical Remission at One Year

Analysis Chemical Thank You The 174 regulations the EPA is currently working on

Analysis Chemical Thank You What we expect the EPA to do in April 2024

Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Analysis Chemical Thank You What we expect the EPA to do in December 2023

Analysis Chemical Thank You Highlights of the EPA’s Unified Agenda for Spring 2023

Analysis Life Sciences Thank You Workshop addresses oncology dose optimization across full span of development

Unblock My Hormones And Start Burning Fat TODAY With HB5

Analysis Chemical Thank You What we expect the EPA to do in February

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

How the Fifty States View Electronic Data as a “Product”

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Pretty Potent Mix In A Prescription Painkiller Preemption Decision

Stay Connected